Portfolio, program, and project management in thepharmaceutical and biotechnology industries

This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expertauthors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years. The editor, Pete Harpum, is convinced that high quality program and project management is fundamental to the emerging strategies for this sector to remain competitive, continue to deliver good returns to investors, and ultimately to bring novel personalized medicine to patients. The authors in the book provide the substance to support these views.Pete Harpum is director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P3M) for some ten years. He chairs and contributes to many conferences and symposiums on P3M. Mr. Harpum's other activities include post-graduate lecturing and research on P3M for three world class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.

• ISBN: 978-0-470-04966-2
• Editorial: John Wiley & Sons
• Encuadernacion: Cartoné
• Páginas: 331
• Fecha Publicación: 16/04/2010
• Nº Volúmenes: 1
• Idioma: Inglés